Clinical Form | Sex | OR | 95 % CI |
P-value* |
---|
| Male | Female | | | |
Controls1,2,4
| 12 | 2 | | | |
Cutaneous L1,3,5
| 55 | 10 | 1.1 | 0.21–5.63 |
10.9172 |
Mucosal L2,3,6
| 13 | 7 | 3.2 | 0.55–18.72 |
20.1779 |
| | | 3.0 | 0.95–9.26 |
30.0551 |
Disseminated L4,5,6
| 26 | 2 | 0.5 | 0.06–3.68 |
40.4572 |
| | | 0.4 | 0.09–2.07 |
50.2768 |
| | | 0.1 | 0.02-0.79 |
60.0148 |
- *P value analyzed by the χ
2 test. Note: Odds ratios (OR) and χ
2 tests were performed with groups that bear the same number in superscript; the respective odds ratio, 95 % confidence interval (CI), and P-value for each comparison has the same number in superscript. No statistically significant differences were found